Related Experiment Video
Updated: Jul 1, 2026

Parasite Induced Genetically Driven Autoimmune Chagas Heart Disease in the Chicken Model
Published on: July 29, 2012
Complement Factor H as a potential atherogenic marker in chronic Chagas' disease
K C F Lidani1, T L Sandri1,2, F A Andrade1
1Laboratory of Molecular Immunopathology, Clinical Hospital, Federal University of Paraná, Curitiba, Brazil.
Insights
Plasma levels of complement Factor H (FH) correlate with metabolic issues in chronic Chagas' disease (CD). Higher FH links to dyslipidemia and inflammation, suggesting a role in immune and metabolic dysregulation in CD patients.
Area of Science:
- Immunology
- Cardiology
- Metabolic Disorders
Background:
- Chronic Chagas' disease (CD) involves complex immune and metabolic alterations.
- The role of complement Factor H (FH) in the pathogenesis of CD, particularly cardiac involvement and metabolic parameters, remains under-investigated.
Purpose of the Study:
- To investigate the association between plasma Factor H (FH) levels and cardiac involvement, inflammatory, and cardiometabolic parameters in patients with chronic Chagas' disease (CD).
Main Methods:
- Plasma FH levels were measured in 80 chronic CD patients.
- Cardiometabolic parameters (glycemic index, lipidogram, BMI, blood pressure) and inflammatory marker (uCRP) were analyzed.
- Cardiac function (LVEF) was assessed via echocardiography.
- Statistical analyses included Mann-Whitney and Spearman correlation tests.
Main Results:
- FH levels positively correlated with triglycerides, LDL-C, total cholesterol, uCRP, and BMI.
- FH levels negatively correlated with HDL-C.
- Dyslipidemic patients exhibited higher FH levels compared to normolipidemic patients.
- No significant difference in FH levels was found between different clinical forms of chronic CD.
Conclusions:
- Complement Factor H (FH) is associated with cardiometabolic and inflammatory parameters in chronic Chagas' disease (CD).
- The alternative complement pathway may link immune response and metabolic disorders in CD.
- FH plays a potential immunoregulatory role in the context of metabolic disturbances in chronic CD.
Abstract:
We aimed to investigate the association between plasma levels of complement Factor H (FH) with cardiac involvement, inflammatory and cardiometabolic parameters in patients with chronic Chagas' disease (CD). FH plasmatic levels were determined in 80 chronic CD patients. Glycaemic index, lipidogram (high-density lipoprotein cholesterol HDL-C, low-density lipoprotein cholesterol LDL-C, triglycerides and total cholesterol) and Ultrasensitive C-Reactive Protein (uCRP) values were obtained from medical records. Height, weight, body mass index (BMI) blood pressure and left ventricular ejection fraction (LVEF) were obtained from echocardiography examinations. Comparisons between chronic CD clinical forms were performed using Mann-Whitney test and correlation Spearman's test. FH levels were correlated positively with triglycerides (P = .001, r = .39), LDL-C (P = .009, r = .3), cholesterol (P = .02, r = .28), uCRP (P = .029, r = .31) and BMI (P = .008, r = .34); and negatively with HDL-C (P = .03, r = -.25) levels. Dyslipidemic patients showed higher FH levels compared to normolipidemic, although no difference for FH levels was observed between chronic CD clinical forms. Alternative pathway of complement may be a link between immune response and metabolic disorders, with important immunoregulatory role in chronic CD.
More Related Videos
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Cardiomyopathy III: Hypertrophic Cardiomyopathy
American Trypanosomiasis

